Spectral Medical Inc. (TSX:EDT)
Canada
· Delayed Price · Currency is CAD 0.650
+0.010 (1.56%)
Feb 21, 2025, 3:57 PM EST
Spectral Medical Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 2.01 | 1.6 | 1.67 | 2 | 2.1 | 2.87 | Upgrade
|
| Revenue Growth (YoY) | 12.32% | -4.14% | -16.48% | -5.00% | -26.74% | -25.31% | Upgrade
|
| Cost of Revenue | 1.21 | 0.94 | 0.68 | 0.79 | 0.63 | 0.65 | Upgrade
|
| Gross Profit | 0.8 | 0.66 | 0.98 | 1.21 | 1.47 | 2.22 | Upgrade
|
| Selling, General & Admin | 10.63 | 9.8 | 7.44 | 5.76 | 9.57 | 6.19 | Upgrade
|
| Other Operating Expenses | 0.42 | - | - | - | 0.15 | -0.06 | Upgrade
|
| Operating Expenses | 12.96 | 11.5 | 8.86 | 7.26 | 10.02 | 6.41 | Upgrade
|
| Operating Income | -12.17 | -10.84 | -7.88 | -6.05 | -8.55 | -4.19 | Upgrade
|
| Interest Expense | -2.67 | -1.33 | -0.18 | -0.03 | -0.03 | -0.04 | Upgrade
|
| Earnings From Equity Investments | -0.19 | -0.4 | 1 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.21 | 0.13 | -0.04 | -0.05 | 0.01 | -0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | -9.16 | -2.46 | -0.36 | -0.7 | -0.54 | -0.51 | Upgrade
|
| EBT Excluding Unusual Items | -24.4 | -14.91 | -7.46 | -6.83 | -9.11 | -4.85 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.6 | -0.6 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.17 | 0.03 | 0.02 | -0.01 | Upgrade
|
| Asset Writedown | - | - | - | -0.16 | - | - | Upgrade
|
| Pretax Income | -25 | -15.51 | -7.63 | -6.96 | -9.1 | -4.86 | Upgrade
|
| Earnings From Continuing Operations | -25 | -15.51 | -7.63 | -6.96 | -9.1 | -4.86 | Upgrade
|
| Earnings From Discontinued Operations | -0.03 | -0.16 | -3.65 | -1.83 | - | - | Upgrade
|
| Net Income | -25.03 | -15.66 | -11.28 | -8.79 | -9.1 | -4.86 | Upgrade
|
| Net Income to Common | -25.03 | -15.66 | -11.28 | -8.79 | -9.1 | -4.86 | Upgrade
|
| Shares Outstanding (Basic) | 280 | 279 | 270 | 252 | 233 | 226 | Upgrade
|
| Shares Outstanding (Diluted) | 280 | 279 | 270 | 252 | 233 | 226 | Upgrade
|
| Shares Change (YoY) | 0.78% | 3.23% | 6.88% | 8.59% | 3.00% | 2.52% | Upgrade
|
| EPS (Basic) | -0.09 | -0.06 | -0.04 | -0.03 | -0.04 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.09 | -0.06 | -0.04 | -0.03 | -0.04 | -0.02 | Upgrade
|
| Free Cash Flow | -8.87 | -10.91 | -9.93 | -9.18 | -0.64 | -2.9 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.04 | -0.04 | -0.04 | -0.00 | -0.01 | Upgrade
|
| Gross Margin | 39.78% | 41.43% | 58.97% | 60.47% | 70.11% | 77.34% | Upgrade
|
| Operating Margin | -606.43% | -678.35% | -472.71% | -303.26% | -406.85% | -146.06% | Upgrade
|
| Profit Margin | -1247.96% | -980.10% | -676.72% | -440.13% | -433.03% | -169.46% | Upgrade
|
| Free Cash Flow Margin | -441.97% | -682.48% | -595.86% | -460.12% | -30.41% | -101.08% | Upgrade
|
| EBITDA | -12.06 | -10.73 | -7.7 | -5.85 | -8.34 | -4.01 | Upgrade
|
| EBITDA Margin | - | - | - | -293.19% | - | -139.64% | Upgrade
|
| D&A For EBITDA | 0.11 | 0.11 | 0.18 | 0.2 | 0.21 | 0.18 | Upgrade
|
| EBIT | -12.17 | -10.84 | -7.88 | -6.05 | -8.55 | -4.19 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -146.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.